Description

Dapasmart M is a combination oral antidiabetic medication containing Dapagliflozin (an SGLT2 inhibitor) and Metformin Hydrochloride Extended-Release (a biguanide). It is prescribed for the management of type 2 diabetes mellitus in adults when diet, exercise, and single-drug therapy are not sufficient to achieve optimal blood glucose control. This combination helps improve glycemic control while offering the convenience of a once-daily extended-release formulation. Key Benefits Helps lower and maintain healthy blood sugar levels. Promotes urinary excretion of excess glucose through the kidneys. Reduces glucose production in the liver and improves insulin sensitivity. Extended-release metformin provides gradual drug release for sustained blood sugar control. May support modest weight loss and offers cardiovascular and kidney benefits in appropriate patients with type 2 diabetes. How It Works Dapagliflozin blocks the sodium-glucose co-transporter-2 (SGLT2) in the kidneys, allowing excess glucose to be eliminated through urine. Metformin Extended-Release decreases glucose production by the liver, improves the body's response to insulin, and reduces glucose absorption from the intestine. Together, these actions provide effective and sustained blood sugar management. Indications Dapasmart M is indicated for: Management of type 2 diabetes mellitus in adults. Improving glycemic control alongside a healthy diet and regular exercise. Use as prescribed by a healthcare professional when combination therapy is appropriate. Dosage and Administration Take exactly as prescribed by your physician. Swallow the extended-release tablet whole with water; do not crush, chew, or split. Preferably take with food to reduce gastrointestinal discomfort. Follow a balanced diet and regular exercise program for best results. Possible Side Effects Common side effects may include: Frequent urination Increased thirst Nausea or diarrhea Stomach discomfort Headache Genital yeast infections or urinary tract infections Seek immediate medical attention if you experience symptoms of severe allergic reactions, lactic acidosis, or diabetic ketoacidosis. Precautions Not intended for the treatment of type 1 diabetes. Use with caution in patients with kidney or liver impairment. Avoid excessive alcohol consumption during treatment. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Regular monitoring of kidney function and blood glucose is recommended. Storage Store below 25°C in a cool, dry place away from moisture, heat, and direct sunlight. Keep out of reach of children. Disclaimer: Dapasmart M is a prescription medicine and should only be used under the supervision of a qualified healthcare professional.